MRCP2-1932

A 36-year-old patient with locally advanced breast cancer arrives at the Emergency Department 48 hours after receiving her first round of chemotherapy, reporting restlessness and facial grimacing. According to her medical records, her treatment plan was classified as having a moderate risk of causing emesis (30-60%). Which medication is the probable cause of her symptoms?